首页 | 本学科首页   官方微博 | 高级检索  
检索        

不同三维探测器对鼻咽癌VMAT计划MLC位置误差探测灵敏度的研究
引用本文:张朋,闫冰,薛旭东,吴爱东.不同三维探测器对鼻咽癌VMAT计划MLC位置误差探测灵敏度的研究[J].中华放射肿瘤学杂志,2019,28(7):527-531.
作者姓名:张朋  闫冰  薛旭东  吴爱东
作者单位:安徽医科大学生命科学学院生物医学工程系,合肥 230032;中国科学技术大学附属第一医院放疗科,合肥 230001
基金项目:安徽省自然科学基金青年项目(1808085QH281)
摘    要:目的 研究鼻咽癌容积旋转调强(VMAT)计划剂量验证中,Delta4和ArcCHECK两种三维探测器对多叶准直器(MLC)叶片位置误差检测的灵敏度。方法 选取10例鼻咽癌VMAT计划,对原始文件中每个MLC子野的叶片分别引入0.5~4.0 mm的位置误差,使子野整体扩大、缩小或偏向一侧平移,模拟VMAT治疗中MLC可能出现的位置误差。分别用Delta4和ArcCHECK进行验证测量,比较计划系统计算值与测量结果的γ通过率并行配对t检验。结果 当评价标准取3 mm/3%时,两种探测器所有患者的原计划验证绝对剂量γ通过率均>95%,Delta4和ArcCHECK可以检测出的MLC外扩、内收以及平移误差分别是1.5、1.0、2.0 mm和3.0、1.0、3.0 mm;而取2 mm/2%评价标准时,患者原计划验证绝对剂量γ通过率有较大幅度下降,此时Delta4和ArcCHECK能检出的MLC外扩、内收和平移误差分别是1.0、1.0、2.0 mm和1.5、0.5、2.0 mm。结论 Delta4和ArcCHECK鼻咽癌VMAT计划的剂量验证可以检测出不同类型和大小的MLC位置误差,但两者的检测灵敏性略有差异,而对<1.0 mm微小误差的检测都不够敏感,日常工作中仍需加强MLC的质量保证。

关 键 词:灵敏度  质量控制  多叶准直器  鼻咽肿瘤/容积调强弧形治疗  
收稿时间:2018-05-30

Study on the sensitivity of different 3D detectors to MLC positioning errors in volumetric modulated arc therapy (VMAT) plan for nasopharyngeal carcinoma
Zhang Peng,Yan Bing,Xue Xudong,Wu Aidong.Study on the sensitivity of different 3D detectors to MLC positioning errors in volumetric modulated arc therapy (VMAT) plan for nasopharyngeal carcinoma[J].Chinese Journal of Radiation Oncology,2019,28(7):527-531.
Authors:Zhang Peng  Yan Bing  Xue Xudong  Wu Aidong
Institution:Department of Biomedical Engineering,College of Life Sciences,Anhui Medical University,Hefei 230032,China;Department of Radiation Oncology,First Affiliated Hospital of University of Science and Technology of China,Hefei 230001,China
Abstract:Objective To compare the sensitivity of Delta4 and ArcCHECK 3D detectors to detect the multi-leaf collimator (MLC) positioning errors in the dose verification of volumetric modulated arc therapy (VMAT) plans for nasopharyngeal carcinoma (NPC). Methods Ten NPC patients receiving VMAT plans were selected. The positioning error of 0.5-4.0 mm was introduced into the leaves of each MLC segment in the original file to expand,contract or shift the whole segments. The possible positioning errors of MLC in the treatment of VMAT were simulated. The Delta4 and ArcCHECK were utilized to verify the measurements. The absolute gamma passing rate was compared between the calculated dose and the measured dose of the VMAT plan by using the paired t-test. Results When the evaluation criterion was taken as 3 mm/3%,the absolute passing rate verified by the original plans of two detectors was greater than 95%. The positioning errors of MLC expansion,contraction and shifting detected by Delta4 and ArcCHECK were 1.5 mm,1.0 mm,2.0 mm and 3.0 mm,1.0 mm,and 3.0 mm,respectively. When taking 2 mm/2% as the evaluation criterion,the absolute passing rate verified by the original plan was decreased significantly. Delta4 and ArcCHECK detected that the positioning errors of MLC expansion,contraction and shifting were 1.0 mm,1.0 mm,2.0 mm and 1.5 mm,0.5 mm,and 2.0 mm,respectively. Conclusions The dose verification of the VMAT plan for NPC by Delta4 and ArcCHECK can detect different types and sizes of MLC positioning errors,whereas the detection sensitivity slightly differs between Delta4 and ArcCHECK. Both of them are not sensitive to detect the MLC positioning errors less than 1.0 mm. It is fairly necessary to strengthen the quality assurance of MLC in the daily work.
Keywords:Sensitivity  Quality control  Multi-leaf collimator  Nasopharyngeal neoplasms/volumetric modulated arc therapy  
点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号